Latest News
Hansoh Pharmaceutical Group Company Limited
- GSK, Hansoh's bone cancer drug delays disease progression in late-stage China study
- Hansoh Pharmaceutical Group (SEHK:3692) Moved Today, What Is Behind The Attention?
- Hansoh Pharmaceutical Group Company Limited Estimates – HKEX:3692
- Hansoh Pharmaceutical Group Company Limited News — LSX:A2PLRC
- Roche, Hansoh Launch Up-to-$15B+ Cancer ADC Collaboration
- Roche Collaborates with Hansoh Pharmaceutical to Develop New Drugs in China
- Hansoh’s Weiyong Sun: Roche deal part of strategy to capture more upside
- Roche Partners With China’s Hansoh in Deal That Could Top $15 Billion
- Hansoh Pharma Enters $15 Billion Collaboration and License Agreement with Roche
- Roche, Hansoh Sign Second ADC Pact Covering Preclinical and Roche-Selected Targets
- Roche struck a cancer drug licensing deal with China's Hansoh that could exceed $15 billion
- Hansoh resubmits aumolertinib EU marketing application after data protection revocation
Headlines from the last 30 days, linking to the original publishers. See all market news →